Updates

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE AND NOVARTIS

Oct 22, 2019

Drug Makers Score Big Off of Price Hikes, Sky-High Launch Prices As Americans Read More

CSRXP URGES HOUSE LAWMAKERS TO CONTINUE WORKING ACROSS PARTY LINES TO HOLD BIG PHARMA ACCOUNTABLE

Oct 16, 2019

Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas Read More

BIG PHARMA WATCH: DRUG MAKERS FUNNEL HUNDREDS OF MILLIONS TO NON-PROFIT GROUPS IN STEALTHY LOBBYING CAMPAIGN

Oct 8, 2019

In yet another example of how Big Pharma attempts to game the system, Read More

New Study: Big Pharma Hikes Prices Without Improving Their Drugs

Oct 8, 2019

Unjustified Price Increases Cost Patients And Health Plans Billions Big Pharma Read More

THEY SAID IT! HOUSE LAWMAKERS MAINTAIN COMMITMENT TO BIPARTISAN COOPERATION ON DRUG PRICING

Sep 26, 2019

House E&C Health Subcommittee Reiterate Need for Action to Hold Big Pharma Read More

ICYMI: An Unprecedented Opportunity for Washington to Lower Drug Prices

Sep 25, 2019

An Unprecedented Opportunity for Washington to Lower Drug Prices Lauren Read More

CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus

Sep 23, 2019

Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of Read More

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA FOR “GAMING THE SYSTEM” TO BLOCK COMPETITION

Sep 20, 2019

Members of E&C Consumer Protection Subcommittee Call for Bipartisan Action Read More

CSRxP: House Rx Package Adds to Unprecedented Momentum to Hold Big Pharma Accountable

Sep 19, 2019

Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from Read More

CSRxP: HHS OIG REPORT DRASTICALLY UNDERCUTS BIG PHARMA’S BLAME GAME AT CRITICAL MOMENT IN WASHINGTON

Sep 13, 2019

Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes, Read More

NEW STUDY: BIG PHARMA PRICE-GOUGING MEDICATIONS FOR RARE DISEASES AT STAGGERING RATE

Sep 11, 2019

Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs Read More